Aloe composition and uses thereof

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/199, 195/33

C12N 7/04 (2006.01) A61K 31/715 (2006.01) C07H 15/24 (2006.01) C08B 37/00 (2006.01)

Patent

CA 1336581

Acemannan has now been discovered to be a potent inducer of Interleukin 1 (Il-1) and prostaglandin E2 (PGE2) production by human peripheral blood adherent cells in culture. Il-1 has been shown to be an important macrophage product and is associated with influencing the activity and product production of T lymphocytes, fibroblasts, B lympho- cytes and endothelial cells. Acemannan has no demonstrated toxicity, and acts as an adjuvant and immunoenhancer. Administration of an amount of acemannan sufficient to sti- mulate monocytes and macrophages not only produces Il-1 and PGE2 but also stimulates phagocytosis, increases antibody production, enhances antiviral activity in the serum and, in those patients with AIDS/ARC, produces defective HIV virus. Acemannan has been shown to affect the rate of virus production in viral vaccine master seed cultures by accelerating the rate of viral replication. In addition, acemannan is a potent adjuvant to viral vaccines in chickens. Acemannan has also shown specific antitumor acti- vity against sarcoid tumors in horses.

607449

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aloe composition and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aloe composition and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aloe composition and uses thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1299324

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.